FUSED: Cross-Domain Integration of Foundation Models for Cancer Drug Response Prediction

03 Sept 2025 (modified: 16 Oct 2025)Submitted to NeurIPS 2025 2nd Workshop FM4LSEveryoneRevisionsBibTeXCC BY 4.0
Keywords: drug response prediction, single cell foundation model, molecular foundation model for drugs, cross domain foundation model integration, multi-head attention
TL;DR: We present FUSED, to our knowledge the first architecture that integrates Foundation Models (FMs) from distinct domains (molecular FMs for drugs and single-cell FMs for cell lines), to enable more accurate and robust cancer drug response prediction.
Abstract: AI-driven methods for predicting drug responses hold promise for advancing personalized cancer therapy, but cancer heterogeneity and the high cost of data generation pose substantial challenges. Here we explore the transfer learning capa bility and introduce FUSED (Fusion of Foundation Model Embeddings for Drug Response Prediction), a novel architecture for cross-domain foundation model (FM) integration. By systematically benchmark FMs across two domains– molecular FMfor drugs and single-cell FM for cell lines, we demonstrate that integrating single-cell FMs substantially reduces the number of input features required for cell line representation. Among FMs, Molformer significantly outperforms Chem BERTa, and scGPT surpasses scFoundation in predictive accuracy and training stability. Moreover, integrating single-cell FMs improves performance in both drug-known and leave-one-drug-out scenarios. These findings highlight the poten tial of cross-domain FM integration for more efficient and robust drug response prediction.
Submission Number: 30
Loading